Comparing Medicines Information from Pharmaceutical Representatives in Australia and Malaysia
Author Information
Author(s): Othman Noordin, Vitry Agnes I, Roughead Elizabeth E, Ismail Shaiful B, Omar Khairani
Primary Institution: Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Sciences, University of South Australia
Hypothesis
How does the quality of medicines information provided by pharmaceutical representatives to doctors in Australia compare to that in Malaysia?
Conclusion
Pharmaceutical representatives in both Australia and Malaysia usually provide information on indications and dosages, but often omit important risk information.
Supporting Evidence
- 78% of presentations in Malaysia included approved product information sheets compared to 53% in Australia.
- 90% of doctors in both countries reported receiving information on indications.
- 41% of Australian presentations and 36% of Malaysian presentations included information on adverse effects.
Takeaway
Doctors in Australia and Malaysia get information about medicines from salespeople, but they often miss important safety details.
Methodology
General practitioners filled out questionnaires after encounters with pharmaceutical representatives to assess the information provided.
Potential Biases
Self-reporting by doctors may introduce recall bias.
Limitations
The study had a small sample size and low response rate, which may limit the generalizability of the findings.
Participant Demographics
General practitioners aged 45-54 in Australia and 35-44 in Malaysia, with a majority having postgraduate qualifications.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website